These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22874295)

  • 1. A statistics-based approach of contextualization for adverse drug events detection and prevention.
    Chazard E; Bernonville S; Ficheur G; Beuscart R
    Stud Health Technol Inform; 2012; 180():766-70. PubMed ID: 22874295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data mining to generate adverse drug events detection rules.
    Chazard E; Ficheur G; Bernonville S; Luyckx M; Beuscart R
    IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):823-30. PubMed ID: 21859604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information contextualization in decision support modules for adverse drug event prevention.
    Nies J; Koutkias V; Kilintzis V; Guillot B; Maglaveras N; Pedersen HG; Berg AL; Skjoet P
    Stud Health Technol Inform; 2011; 166():95-104. PubMed ID: 21685615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine use of the "ADE scorecards", an application for automated ADE detection in a general hospital.
    Chazard E; Luyckx M; Beuscart JB; Ferret L; Beuscart R
    Stud Health Technol Inform; 2013; 192():308-12. PubMed ID: 23920566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ADE scorecards: a tool for adverse drug event detection in electronic health records.
    Chazard E; Băceanu A; Ferret L; Ficheur G
    Stud Health Technol Inform; 2011; 166():169-79. PubMed ID: 21685622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward automatic detection and prevention of adverse drug events.
    Leroy N; Chazard E; Beuscart R; Beuscart-Zephir MC;
    Stud Health Technol Inform; 2009; 143():30-5. PubMed ID: 19380911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSIP: an overview of the results and clinical implications.
    Beuscart R
    Stud Health Technol Inform; 2011; 166():3-12. PubMed ID: 21685604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of adverse drug events detection: data aggregation and data mining.
    Chazard E; Ficheur G; Merlin B; Genin M; Preda C; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():75-84. PubMed ID: 19745237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraction of adverse drug effects from clinical records.
    Aramaki E; Miura Y; Tonoike M; Ohkuma T; Masuichi H; Waki K; Ohe K
    Stud Health Technol Inform; 2010; 160(Pt 1):739-43. PubMed ID: 20841784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of adverse drug events: proposal of a data model.
    Chazard E; Merlin B; Ficheur G; Sarfati JC; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():63-74. PubMed ID: 19745236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication related computerized decision support system (CDSS): make it a clinicians' partner!
    Marcilly R; Leroy N; Luyckx M; Pelayo S; Riccioli C; Beuscart-Zéphir MC
    Stud Health Technol Inform; 2011; 166():84-94. PubMed ID: 21685614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a computerized tool allowing retrospective detection of potential vitamin K antagonist overdoses in complex contexts.
    Ferret L; Luyckx M; Merlin B; Ficheur G; Chazard E; Beuscart R
    Stud Health Technol Inform; 2013; 192():553-6. PubMed ID: 23920616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient safety: detection and prevention of adverse drug events.
    Beuscart R; McNair P; Darmoni SJ; Koutkia V; Maglaveras N; Beuscart-Zephir MC; Nohr C;
    Stud Health Technol Inform; 2009; 150():968-71. PubMed ID: 19745457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontology-based knowledge management for personalized adverse drug events detection.
    Cao F; Sun X; Wang X; Li B; Li J; Pan Y
    Stud Health Technol Inform; 2011; 169():699-703. PubMed ID: 21893837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug events prevention rules: multi-site evaluation of rules from various sources.
    Chazard E; Ficheur G; Merlin B; Serrot E; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():102-11. PubMed ID: 19745240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of clinical data entry when using a computerized decision support system: a case study with OncoDoc2.
    Séroussi B; Blaszka-Jaulerry B; Zelek L; Lefranc JP; Conforti R; Spano JP; Rousseau A; Bouaud J
    Stud Health Technol Inform; 2012; 180():472-6. PubMed ID: 22874235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From adverse drug event detection to prevention. A novel clinical decision support framework for medication safety.
    Koutkias VG; McNair P; Kilintzis V; Skovhus Andersen K; Niès J; Sarfati JC; Ammenwerth E; Chazard E; Jensen S; Beuscart R; Maglaveras N
    Methods Inf Med; 2014; 53(6):482-92. PubMed ID: 25377477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative.
    Tham E; Calmes HM; Poppy A; Eliades AB; Schlafly SM; Namtu KC; Smith DM; Vitaska MC; McConnell C; Potts AL; Jastrzembski J; Logsdon TR; Hall M; Takata GS
    Pediatrics; 2011 Aug; 128(2):e438-45. PubMed ID: 21727100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and preventability of adverse drug events in a teaching hospital: a cross-sectional study.
    Benkirane R; Pariente A; Achour S; Ouammi L; Azzouzi A; Soulaymani R
    East Mediterr Health J; 2009; 15(5):1145-55. PubMed ID: 20214128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human factors engineering for computer-supported identification and prevention of adverse drug events.
    Beuscart-Zéphir MC; Nøhr C
    Stud Health Technol Inform; 2009; 148():14-24. PubMed ID: 19745231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.